This inventor holds 1 USPTO granted patent. Top assignee: Musc Foundation for Research Development. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Uday Baliga: Innovator in Osteogenesis Imperfecta Treatment
Introduction
Uday Baliga is a notable inventor based in Charleston, SC (US). He has made significant contributions to the field of medical research, particularly in the treatment of Osteogenesis Imperfecta (OI). His innovative work focuses on enhancing bone remodeling through advanced cellular therapies.
Latest Patents
Uday Baliga holds 1 patent related to T regulatory (Treg) cell transplantation in Osteogenesis Imperfecta. The patent describes compositions comprising induced T regulatory cells (iTregs), methods for creating these compositions, and their application in improving bone remodeling for patients suffering from OI.
Career Highlights
Uday Baliga is affiliated with the Medical University of South Carolina Foundation for Research Development. His work is pivotal in advancing therapeutic strategies for bone disorders, showcasing his commitment to improving patient outcomes through innovative research.
Collaborations
Uday collaborates with esteemed colleagues, including Meenal Mehrotra and In-Hong Kang. Their combined expertise enhances the research efforts aimed at developing effective treatments for complex medical conditions.
Conclusion
Uday Baliga's contributions to the field of Osteogenesis Imperfecta treatment through his innovative patent reflect his dedication to advancing medical science. His work continues to inspire future research and development in the area of regenerative medicine.